These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6201179)

  • 61. Alteration of erythrocytes by reduced species of oxygen generated in hypoxic rat liver during perfusion.
    Gerber G; Siems W; Garbe S; Müller M
    Biomed Biochim Acta; 1987; 46(2-3):S245-7. PubMed ID: 3593303
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Absorption and distribution of vaginally administered misonidazole.
    Ash D; Bugden R; Calvert R
    Cancer Chemother Pharmacol; 1982; 9(2):118-9. PubMed ID: 7172406
    [No Abstract]   [Full Text] [Related]  

  • 63. Pharmacokinetic considerations of misonidazole in therapeutics.
    Matheson I; Plowman PN; Johnston A
    Hum Toxicol; 1984 Feb; 3(1):29-36. PubMed ID: 6698564
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Kinetics of misonidazole enantiomers.
    Williams KM
    Clin Pharmacol Ther; 1984 Dec; 36(6):817-23. PubMed ID: 6499361
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Quantitative evaluation of plasma free fatty acid uptake by the isolated perfused rat liver. Influence of hypoxia.
    Soler-Argilaga C; Infante R; Polonovski J; Caroli J
    Biochim Biophys Acta; 1971 Jul; 239(2):154-61. PubMed ID: 5119253
    [No Abstract]   [Full Text] [Related]  

  • 66. Effects of cimetidine, antipyrine, and pregnenolone carbonitrile on misonidazole pharmacokinetics.
    Workman P; Donaldson J; Smith NC
    Cancer Treat Rep; 1983; 67(7-8):723-5. PubMed ID: 6871889
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hypoxic fraction and binding of misonidazole in EMT6/Ed multicellular tumor spheroids.
    Franko AJ
    Radiat Res; 1985 Jul; 103(1):89-97. PubMed ID: 4070561
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state.
    Arteel GE; Thurman RG; Raleigh JA
    Eur J Biochem; 1998 May; 253(3):743-50. PubMed ID: 9654074
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hypoxic damage generates reactive oxygen species in isolated perfused rat liver.
    Jaeschke H; Smith CV; Mitchell JR
    Biochem Biophys Res Commun; 1988 Jan; 150(2):568-74. PubMed ID: 3342037
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Induced hypoxia in rat pulp and periapex demonstrated by 3H-misonidazole retention.
    Baumgardner KR; Walton RE; Osborne JW; Born JL
    J Dent Res; 1996 Oct; 75(10):1753-60. PubMed ID: 8955670
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of phenytoin, phenobarbital, and ascorbic acid on misonidazole elimination.
    Williams K; Begg E; Wade D; O'Shea K
    Clin Pharmacol Ther; 1983 Mar; 33(3):314-21. PubMed ID: 6825387
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Generation of nitro radical anions of some 5-nitrofurans, and 2- and 5-nitroimidazoles by rat hepatocytes.
    Rao DN; Jordan S; Mason RP
    Biochem Pharmacol; 1988 Aug; 37(15):2907-13. PubMed ID: 2840082
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients.
    Moore JL; Paterson IC; Newman H; Venables S
    Br J Cancer; 1981 Oct; 44(4):592-6. PubMed ID: 7295516
    [No Abstract]   [Full Text] [Related]  

  • 74. Killing of EMT-6 cells by decays from isotopes incorporated on sensitizer adducts.
    Roa WH; Chapman JD
    Radiat Res; 1992 Nov; 132(2):248-53. PubMed ID: 1438707
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models.
    Mahy P; De Bast M; de Groot T; Cheguillaume A; Gillart J; Haustermans K; Labar D; Grégoire V
    Radiother Oncol; 2008 Dec; 89(3):353-60. PubMed ID: 18649964
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reductive metabolism and activation of benznidazole.
    Masana M; de Toranzo EG; Castro JA
    Biochem Pharmacol; 1984 Apr; 33(7):1041-5. PubMed ID: 6712714
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The radiation reduction in misonidazole.
    Whillans DW; Whitmore GF
    Radiat Res; 1981 May; 86(2):311-24. PubMed ID: 7232695
    [No Abstract]   [Full Text] [Related]  

  • 78. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours.
    Raleigh JA; Miller GG; Franko AJ; Koch CJ; Fuciarelli AF; Kelly DA
    Br J Cancer; 1987 Oct; 56(4):395-400. PubMed ID: 3689657
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A drug for improved radiosensitization in radiotherapy.
    Dische S; Fowler JF; Saunders MI; Stratford MR; Anderson P; Minchinton AI; Lee ME
    Br J Cancer; 1980 Jul; 42(1):153-5. PubMed ID: 7426325
    [No Abstract]   [Full Text] [Related]  

  • 80. Effect of hypoxic perfusion on hepatic concentration and biliary release of glutathione disulfide.
    Cummings SW; Hill KE; Burk RF; Ziegler DM
    Biochem Pharmacol; 1988 Mar; 37(5):967-9. PubMed ID: 3345206
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.